Anti-WF10A/ WFDC10A/ C20orf146 functional antibody

Anti-WF10A/ WFDC10A/ C20orf146 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to WFDC10A/WFDC10A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1373-Ab-1/ GM-Tg-hg-SE1373-Ab-2Anti-Human WFDC10A monoclonal antibodyHuman
GM-Tg-rg-SE1373-Ab-1/ GM-Tg-rg-SE1373-Ab-2Anti-Rat WFDC10A monoclonal antibodyRat
GM-Tg-mg-SE1373-Ab-1/ GM-Tg-mg-SE1373-Ab-2Anti-Mouse WFDC10A monoclonal antibodyMouse
GM-Tg-cynog-SE1373-Ab-1/ GM-Tg-cynog-SE1373-Ab-2Anti-Cynomolgus/ Rhesus macaque WFDC10A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1373-Ab-1/ GM-Tg-felg-SE1373-Ab-2Anti-Feline WFDC10A monoclonal antibodyFeline
GM-Tg-cang-SE1373-Ab-1/ GM-Tg-cang-SE1373-Ab-2Anti-Canine WFDC10A monoclonal antibodyCanine
GM-Tg-bovg-SE1373-Ab-1/ GM-Tg-bovg-SE1373-Ab-2Anti-Bovine WFDC10A monoclonal antibodyBovine
GM-Tg-equg-SE1373-Ab-1/ GM-Tg-equg-SE1373-Ab-2Anti-Equine WFDC10A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1373-Ab-1/ GM-Tg-hg-SE1373-Ab-2; GM-Tg-rg-SE1373-Ab-1/ GM-Tg-rg-SE1373-Ab-2;
GM-Tg-mg-SE1373-Ab-1/ GM-Tg-mg-SE1373-Ab-2; GM-Tg-cynog-SE1373-Ab-1/ GM-Tg-cynog-SE1373-Ab-2;
GM-Tg-felg-SE1373-Ab-1/ GM-Tg-felg-SE1373-Ab-2; GM-Tg-cang-SE1373-Ab-1/ GM-Tg-cang-SE1373-Ab-2;
GM-Tg-bovg-SE1373-Ab-1/ GM-Tg-bovg-SE1373-Ab-2; GM-Tg-equg-SE1373-Ab-1/ GM-Tg-equg-SE1373-Ab-2
Products NameAnti-WFDC10A monoclonal antibody
Formatmab
Target NameWFDC10A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-WFDC10A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1373-Ag-1Recombinant multi-species WF10A/ WFDC10A/ C20orf146 protein


    Target information

    Target IDGM-SE1373
    Target NameWFDC10A
    Gene ID140832,685216,717384,100296236,100629250
    Gene Symbol and SynonymsC20orf146,dJ688G8.3,WAP10,Wfdc10,WFDC10A
    Uniprot AccessionQ9H1F0
    Uniprot Entry NameWF10A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000180305
    Target ClassificationN/A

    The target: WFDC10A, gene name: WFDC10A, also named as C20orf146, WAP10, dJ688G8.3. This gene encodes a member of the WAP-type four-disulfide core (WFDC) domain family. The WFDC domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the telomeric cluster. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.